Biography
Fisal Tantoush joined the Global Health and Infection Department at Brighton and Sussex Medical School in May 2024 as a Research Fellow in Immunology, where he focuses on the neglected tropical disease Podoconiosis in Ethiopia and Rwanda. Recently, he undertook a significant initiative in Rwanda, where he provided advanced training to junior PhD students, thereby contributing to the development of local research capacity.
Dr. Tantoush holds a PhD in Immunology from Hull York Medical School (University of Hull), where he cultivated extensive expertise in molecular and cellular immunology, with a particular emphasis on T and B cells. In addition, he earned a master’s degree in biomedical sciences with distinction from the University of Hull and a BSc in Medical Laboratories from Tripoli University.
During his doctoral research, Dr. Tantoush explored the role of bacterial superantigens in T cell exhaustion among chronic lymphocytic leukaemia (CLL) patients, elucidating the mechanisms by which these superantigens contribute to immune dysfunction and heighten the risk of severe infections (e.g., Sepsis). He demonstrated advanced competencies in the manipulation and analysis of human and murine primary cells and tissues, flow cytometry, next-generation sequencing (NGS), and sophisticated data analysis. His research has been disseminated at prestigious forums, including the British Society for Immunology (BSI) conferences, where he was awarded travel grants ([link to published report]).
Beyond his research, Dr. Tantoush has actively engaged in lab-wide dissemination activities and teaching responsibilities, gaining valuable experience in public engagement and the mentorship of students. His work is further distinguished by a robust track record of collaboration in immunology and cardiovascular disease research. With excellent organizational skills and a strong commitment to collaborative research, Dr. Tantoush is dedicated to advancing the field of immunology and leveraging his expertise to address global health challenges.